Episode 21 - Early Adopters of Digital Pathology
Episode 21 - Early Adopters of Digital Pathology
Embedded Files
This episode's guests: Sam Terese
This episode's guests: Sam Terese
Our guest is Sam Terese, president and CEO of Alverno Laboratories, an integrated laboratory delivery network serving multiple healthcare systems and hospitals in the Chicagoland and Indiana area. Sam Terese has more than 30 years of experience in the laboratory environment, including settings as varied as community hospitals, academic medical centers, as well as research based organizations. Alverno, under Sam's leadership, has pursued a strategy of growth and consolidation and offers laboratory medicine, anatomic pathology services, as well as molecular diagnostics.
This episode, we're going to be talking about considerations in going digital. We will examine the advantages of digital pathology to a healthcare system, and the opportunities for improving efficiencies and consolidation. Alverno was an early adopter in taking its anatomic pathology services digital, so we will discuss what it means to be an early adopter. We will look at how digital pathology can enhance the care that pathologists provide to doctors, patients and healthcare systems. We'll discover some considerations in establishing a relationship in a digital pathology platform provider because clearly as we're going to learn, it's not a one-off transaction or a one-time thing, but an ongoing relationship or even a foundation upon which we can build.
Sponsor
More About Sam Terese
More About Sam Terese
Sam Terese, MBA, MT(ASCP) holds the position of Chief Executive Officer and President of Alverno,
Sam Terese has over 40 years of healthcare leadership experience that includes a variety of facilities, including a community hospital academic medical center and a research-based organization. Since 2005, Terese has served as a member of the senior executive team of an integrated laboratory delivery network, Alverno Laboratories and as CEO since 2011. Mr. Terese’s skills include business development, marketing, financial, planning, strategic planning and other management tools along with being well versed in quality assurance practices, principles of Lean, Six Sigma, developing teams, and laboratory operations and health system operations.
Since coming to Alverno in 2005, Mr. Terese facilitated the testing integration of multiple hospital laboratories.
Alverno has greatly expanded testing capabilities in molecular diagnostics, precision medicine and its anatomic pathology services, becoming one the first laboratories to convert to digital pathology. Once completed in 2021,
Alverno will have the largest install of digital scanners in the world. It was also one of the first laboratories to adopt microbiology automation in the US. Currently, Alverno owns 34 hospital laboratories and partners with several other hospitals and operates an extensive reference laboratory operation.
Mr. Terese holds an M.B.A. from the University of Illinois at Chicago in Strategic Planning and Marketing and bachelor’s degrees in Medical Technology from Rosalind Franklin University Chicago and Biology from the State University of New York at Buffalo.
Page updated
Google Sites
Report abuse